Keywords: irAE; immune related adverse event; ECOG PS; European cooperative oncology group performance status; n.s.; not significant; EGFR; epidermal growth factor receptor; ALK; anaplastic lymphoma kinase; PD-L1; programmed death-ligand 1; TKI; tyrosine-kinase inh
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: kidney neoplasms; nephrectomy; risk factors; watchful waiting; patient care planning; AUA; American Urological Association; EAU; European Association of Urology; ECOG PS; Eastern Cooperative Oncology Group Performance Status; NCCN®; National Comprehensiv
Keywords: prostatic neoplasms; castration-resistant; subcutaneous fat; prognosis; tomography; x-ray computed; mortality; ADT; androgen deprivation therapy; ARAT; androgen receptor axis targeted; BMI; body mass index; CCI; Charlson Comorbidity Index; CRPC; castratio
Keywords: SCLC; small cell lung cancer; CECT; contrast enhanced computed tomography; CT; computed tomography; PET CT; positron emission tomography - computed tomography; ECOG PS; Eastern co-operative oncology group performance status; AJCC; American Joint Committ
Keywords: RT; radiation therapy; IMRT; intensity modulated radiation therapy; CT; computed tomography; Ct.Th; cortical thickness; FN; femoral neck; trBMD; trabecular bone mineral density; CRT; chemo-radiation therapy; SCC; squamous cell carcinoma; SEER; Surveillanc
Keywords: Eribulin; Metastatic breast cancer; First-line; Microtubule; Dose-intensity; ALT; alanine aminotransferase; AST; aspartate aminotransferase; CI; confidence interval; CR; complete response; DCR; disease control rate; DOR; duration of response; ECOG PS; Eas
Keywords: ECOG PS; Novel oral nucleoside; Salvage line chemotherapy; TAS-102; With and without previous Regorafenib;
Keywords: kidney; carcinoma; renal cell; lymph node dissection; nephrectomy; neoplasm metastasis; C-index; concordance index; CSS; cancer specific survival; ECOG PS; Eastern Cooperative Oncology Group performance status; LDH; lactate dehydrogenase; LN; lymph node;
Keywords: ALT; alanine aminotransferase; AML; acute myeloid leukemia; AST; aspartate aminotransferase; BUN; blood urea nitrogen; CR; complete response; CRi; complete response with incomplete blood count recovery; ECOG PS; Eastern Cooperative Oncology Group Performa
Keywords: HCC; hepatocellular carcinoma; TTP; time to progression; NTUH; National Taiwan University Hospital; OS; overall survival; BCLC; Barcelona Clinic Liver Cancer; CLIP; Cancer of the Liver Italian Program; ECOG PS; Eastern Cooperative Oncology Group performan
Impact of a comprehensive geriatric assessment to manage elderly patients with locally advanced non-small-cell lung cancers: An open phase II study using concurrent cisplatin-oral vinorelbine and radiotherapy (GFPC 08-06)
Keywords: ALK; anaplastic lymphoma kinase gene; CGA; comprehensive geriatric assessment; CT; computed-tomography scan; EGFR; epidermal growth-factor; ECOG PS; Eastern Cooperative Oncology Group performance status; La-NSCLC; locally advanced non-small-cell lung ca
Efficacy and safety of nivolumab in previously treated patients with non-small cell lung cancer: A multicenter retrospective cohort study
Keywords: AE; adverse event; ALK; anaplastic lymphoma kinase; CR; complete response; DCR; disease control rate; ECOG PS; Eastern Cooperative Oncology Group Performance Status; EGFR; epidermal growth factor receptor; HR; hazard ratio; irAE; immune related adverse ev
Hepatocellular carcinoma treated with sorafenib: Arterial tumor perfusion in dynamic contrast-enhanced CT as early imaging biomarkers for survival
Keywords: HCC; hepatocellular carcinoma; CT; computed tomography; MRI; magnetic resonance imaging; mRECIST; modified response evaluation criteria in solid tumors; TACE; transarterial chemoembolization; HAIC; hepatic arterial infusion chemotherapy; ECOG PS; eastern
Phytosome complex of curcumin as complementary therapy of advanced pancreatic cancer improves safety and efficacy of gemcitabine: Results of a prospective phase II trial
Keywords: CM; complementary medicine; CT; computerized tomography; DCR; disease control rate; ECOG PS; Eastern Cooperative Oncology Group performance status; EMA; European Medicines Agency; EORTC QLQ-C30; European Organization for Research and Treatment of Cancer Q
Phase I clinical trials in patients with advanced non-small cell lung cancer treated within a Drug Development Unit: What have we learnt?
Keywords: ALK; Anaplastic Lymphoma Kinase; DDU; Drug Development Unit; ECOG PS; Eastern Cooperative Oncology Group performance status; EGFR; epidermal growth factor receptor; EPR; electronic patient record; HDAC; histone deacetylase; IGF-1R; insulin growth factor-1
Evaluation of the VeriStrat® serum protein test in patients with advanced squamous cell carcinoma of the lung treated with second-line afatinib or erlotinib in the phase III LUX-Lung 8 study
Keywords: AE; adverse event; CI; confidence interval; DBS; dried blood spot; DCR; disease control rate; ECOG PS; Eastern Cooperative Oncology Group performance status; EGFR; epidermal growth factor receptor; HER; human epidermal growth factor receptor; HR; hazard r
Observational registry of sorafenib use in clinical practice across Child-Pugh subgroups: The GIDEON study
Keywords: HCC; hepatocellular carcinoma; GIDEON; Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib; AE; adverse event; BCLC; Barcelona Clinic Liver Cancer; ECOG PS; Eastern Cooperative Oncology Group perfo
Icotinib might be effective for the treatment of leptomeningeal carcinomatosis in non-small cell lung cancer with sensitive EGFR mutations
Keywords: Non-small cell lung cancer; Leptomeningeal carcinomatosis; Epidermal growth factor receptor tyrosine kinase inhibitors; Icotinib; ECOG PS;
Presence of Tumor Necrosis is Not a Significant Predictor of Survival in Clear Cell Renal Cell Carcinoma: Higher Prognostic Accuracy of Extent Based Rather Than Presence/Absence Classification
Keywords: necrosis; carcinoma; renal cell; kidney neoplasms; survival; ccRCC; clear cell renal cell carcinoma; CSS; cancer specific survival; ECOG PS; Eastern Cooperative Oncology Group performance status; RCC; renal cell carcinoma;
Impact of Lymph Node Dissection on Cancer Specific Survival in Patients With Upper Tract Urothelial Carcinoma Treated With Radical Nephroureterectomy
Keywords: lymph node excision; prognosis; urologic neoplasms; carcinoma; transitional cell; survival; CIS; carcinoma in situ; CSS; cancer specific survival; DFS; disease-free survival; ECOG PS; Eastern Cooperative Oncology Group performance status; LN; lymph node;
Cytoreductive Nephrectomy for Kidney Cancer With Sarcomatoid Histology-Is Up-Front Resection Indicated and, if Not, is it Avoidable?
Keywords: carcinoma; renal cell; nephrectomy; histology; biological markers; ECOG PS; Eastern Cooperative Oncology Group performance status; PSF; percentage sarcomatoid features; RCC; renal cell carcinoma;
Should Patient-Rated Performance Status Affect Treatment Decisions in Advanced Lung Cancer?
Keywords: NSCLC; ECOG PS; Patient-rated activity level; Congruency of PS rating; Survival
Metachronous Bilateral Renal Cell Carcinoma: Risk Assessment, Prognosis and Relevance of the Primary-Free Interval
Keywords: kidney; carcinoma; renal cell; neoplasms; second primary; risk; prognosis; DSS; disease specific survival; ECOG PS; Eastern Cooperative Oncology Group performance status; IL-2; interleukin-2; NSS; nephron sparing surgery; RCC; renal cell carcinoma; VHL; v